Philadelphia Flyers at New York Rangers NHL Predictions
2026-11-05 • Madison Square Garden
New York Rangers 3 - 2 Philadelphia Flyers
📊 Pre-Game Predictions
Win Probability
NYR: 61.0%
PHI: 39.0%
Expected Goals
NYR: 3.50
PHI: 2.83
Total Goals
Median: 6.3
Over 5.5: 68%
Over 6.5: 49%
🥅 Goalie Matchup
NYR
Dylan Garand - 0-0-0 | 0.000 SV% | 0.00 GAA
PHI
J. Woll
| Stat | NYR | PHI |
|---|---|---|
| Season SV% | 0.000 | — |
| Last 5 SV% | — | — |
| SV% vs Opponent | — | — |
| GAA | 0.00 | — |
Last 5 / vs opponent shown when available in goalie stats. Confirmed goalie row used when available; otherwise current projected starter is shown.
Goalie Game Metrics
| Team | Goalie | SA | Saves | GA | SV% | xGA | HD Faced | GSAx |
|---|---|---|---|---|---|---|---|---|
| NYR | Dylan Garand | 25 | 23 | 2 | 92.0% | 2.78 | 1 | 0.78 |
| PHI | J. Woll | 28 | 25 | 3 | 89.3% | 3.74 | 3 | 0.74 |
SA uses shots on goal plus goals. xGA, high-danger faced, and GSAx use modeled scoring attempts against. GSAx is xGA minus goals against.
Head-to-Head History
Model accuracy in this matchup: 42% • NYR at home vs PHI: 6-4
| Date | Score | Winner | Model Pick |
|---|---|---|---|
| 2026-11-05 | NYR 3 - 2 PHI | NYR | NYR |
| 2026-03-09 | PHI 2 - 6 NYR | NYR | PHI |
| 2026-02-26 | NYR 2 - 3 PHI | PHI | NYR |
| 2026-01-17 | PHI 3 - 6 NYR | NYR | PHI |
| 2025-12-20 | NYR 5 - 4 PHI | NYR | NYR |
Shot Quality by Period
| Period | Team | Shots | High Danger | xG |
|---|---|---|---|---|
| 1 | NYR | 12 | 0 | 1.02 |
| 1 | PHI | 15 | 0 | 0.64 |
| 2 | NYR | 16 | 1 | 0.99 |
| 2 | PHI | 15 | 1 | 1.25 |
| 3 | NYR | 15 | 2 | 1.73 |
| 3 | PHI | 12 | 0 | 0.89 |
Shots are modeled attempts: shots on goal, goals, and missed shots. Blocked shots are excluded. High danger is xG >= 0.20.
🎯 Shot Chart
📈 Post-Game Analysis
Prediction Result
✅ Correct
Confidence: 61.0%
Total Goals
Actual: 5.0
Expected: 6.3
Score Breakdown
New York Rangers 3 - 2 Philadelphia Flyers
Expected: 3.5 - 2.8
Get NHL forecasts in your inbox
Occasional emails with NHL forecasts, analysis, and model updates.